During World Breastfeeding Week, CHOP experts, colleagues cover multiple topics in using human milk in the NICU
Human milk is infant food, but for sick, hospitalized babies, it's also medicine. That's the central premise of a series of articles in a neonatal nursing journal's special issue focused on human milk for sick newborns. The articles are being published during World Breastfeeding Week, Aug. 1-7, 2014.
Multiple public health and professional medical associations from the World Health Organization to the American Academy of Pediatrics have endorsed the widespread advantages of human milk and breastfeeding for all infants. A new issue of Advances in Neonatal Care is devoted to best practices in providing human milk to hospitalized infants.
"The immunological and anti-inflammatory properties of human milk are especially important for the critically ill infants in our intensive care units," said Diane L. Spatz, Ph.D., R.N.-B.C., FAAN, nurse researcher and director of the Lactation Program at The Children's Hospital of Philadelphia (CHOP), and the invited guest editor of the August 2014 issue of the journal, published by the National Association of Neonatal Nurses.
An internationally prominent lactation expert, Spatz leads a robust breastfeeding and Lactation Program at CHOP. CHOP is already on the cutting edge of human milk science and lactation services with a state-of-the-art Human Milk Management Center, and round-the-clock support from nurses and international board-certified lactation consultants, as well as wide-spread institutional support. At CHOP, more than four out of five infants discharged from the Hospital's intensive care units are receiving human milk.
The Hospital has used donor human milk since 2006 for at-risk infants to supplement a mother's own milk supply if it is insufficient or if the mother is unable to provide milk for her infant. This week, CHOP announced plans to launch a non-profit milk bank with the Human Milk Banking Association of North America within a year, an onsite resource not commonly offered within a U.S. children's hospital.
In the special issue, Spatz and her colleagues from CHOP and other institutions cover a variety of topics on the provision of human milk in the neonatal intensive care unit (NICU), including original research articles, ethical rationales for the provision of human milk, and evidence-based methods for implementing particular programs.
Additional articles in the issue examine these topics:
"Supporting the use of human milk is one of the most effective evidence-based strategies to ensure an infant's safe journey through the NICU and promote optimal health and developmental outcomes for these children," added Spatz. "This special edition provides clinicians with tools in order to transform human milk and breastfeeding practices in their own institutions."
In addition to her CHOP position, Spatz holds a joint appointment as a Professor of Perinatal Nursing and the Helen M. Shearer Professor of Nutrition at the University of Pennsylvania School of Nursing.
Advances in Neonatal Care, August 2014.
About The Children's Hospital of Philadelphia:
The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program receives the highest amount of National Institutes of Health funding among all U.S. children's hospitals. In addition, its unique family-centered care and public service programs have brought the 535-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.
Alison Fraser | Eurek Alert!
Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin
Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
29.05.2017 | Earth Sciences
29.05.2017 | Life Sciences
29.05.2017 | Physics and Astronomy